TP53 and breast cancer: HGSCs, the most common type II tumors, feature tumor protein 53 (TP53) mutations and multiple gene modifications (e.g., breast cancer gene or BRCA1/2), which lead to homologous recombination (HR) anomalies [15, 18, 20].